Quest Diagnostics (DGX) Current Leases (2019 - 2026)

Quest Diagnostics has disclosed Current Leases across 8 years of filings, most recently posting $174.0 million for Q1 2026.

• Current Leases for Q1 2026 came in at $174.0 million, up 0.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.0 million (up 0.58% YoY), and the FY2025 annual result was $174.0 million, up 0.58% from the prior year.
• Current Leases came in at $174.0 million for Q1 2026 at Quest Diagnostics, roughly flat from $174.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $176.0 million in Q3 2024 to a low of $153.0 million in Q3 2022.
• The 5-year median for Current Leases is $157.0 million (2023), against an average of $162.5 million.
• Across the five-year window, Current Leases climbed 13.07% in 2024 and retreated 1.7% in 2025, its largest moves.
• Quest Diagnostics' Current Leases stood at $153.0 million in 2022, then changed by 0.0% to $153.0 million in 2023, then climbed by 13.07% to $173.0 million in 2024, then gained by 0.58% to $174.0 million in 2025, then changed by 0.0% to $174.0 million in 2026.
• The last three Current Leases figures came in at $174.0 million (Q1 2026), $174.0 million (Q4 2025), and $173.0 million (Q3 2025), per Business Quant data.